Activins - Open Access .click

Results 151 to 160 of about 20,228 (237)

Revealing Sexual Dimorphism in Prolactin Regulation From Early Postnatal Development to Adulthood in Murine Models. [PDF]

J Endocr Soc, 2023
Abeledo-Machado A +3 more
europepmc +1 more source

Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta‐Analysis

Aging Cell, Volume 25, Issue 2, February 2026.
This systematic review and meta‐analysis identifies blood‐based biomarkers (BBMs) reported in sarcopenia trials, investigating the impact of sarcopenia interventions on BBMs concentrations. Significant heterogeneity was observed in sarcopenia outcomes. Interventions had a limited impact on BBMs, except for IGF‐1, which was significantly impacted by the
Emma Calluy +10 more
wiley +1 more source

Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 803-816, February 2026.
Abstract Treatment with GLP‐1 receptor agonists (GLP‐1 RAs) is effective in reducing body weight in individuals with overweight and type 2 diabetes (T2D). However, measurements indicate that a considerable portion of the weight loss derives from fat‐free mass (FFM), including skeletal muscle, which may compromise metabolic health and physical function.
Viktor Aimelet, Jens Juul Holst
wiley +1 more source

Activins in adipogenesis and obesity

International Journal of Obesity, 2013
Christian Dani
semanticscholar +1 more source

Ο βιοδείκτης activin B στην παλίνδρομη και εξωμήτρια κύηση [PDF]

, 2015
Ζαφείρη, Αθανασία
core +1 more source

Key role for inhibins in effective T cell activation, migration and Th17 differentiation. [PDF]